Comment
Comment by kilimounjaro
Are you talking about acalabrutinib and zanubrutinib? If so, have you looked into the chinese version Orelabrutinib? Chinese pharma has gone from backwater to competitive with US in like 5 years
Be the first to share your thoughts.